NT-pro BNP levels in MDCO-216 hypertension mice were reduced by 19.0% (p < 0.01) and by 11.7% (p < 0.01) compared to reference hypertension mice and buffer hypertension mice, respectively. This evidence concerns the gene NPPB and hypertensive disorder.